Pharmacokinetics of Viral and Non-Viral Gene Delivery Vectors

Pharmacokinetics and Pharmacodynamics of Biotech Drugs: Principles and Case Studies in Drug Development

Volumn , Issue , 2006, Pages 121-144

  Meyer, Martin ^a   Rao, Gururaj ^a   Ren, Ke ^a   Hughes, Jeffrey ^b  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Anatomical considerations; Biotech drugs; Gene therapy; Naked DNA; Non viral vectors; Pharmacodynamics; Pharmacokinetics; Viral and non viral gene delivery vectors; Viral vectors

Indexed keywords

EID: 84889798911     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527609628.ch5     Document Type: Chapter

References (91)

1. Bennett H.S., Luft J.H., and Hampton J.C. 1959. Morphological classification of vertebrate blood capillaries. Am. J. Physiol. 196(2):381-390.
2. Nishikawa, M., and L. Huang. 2001. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene. Ther. 12 : 861-870.
3. Houk, B.E., G. Hochhaus, and J.A. Hughes. 1999. Kinetic modeling of plasmid DNA degradation in rat plasma. AAPS PharmSci. 1:E9.
4. Kawabata, K., Y. Takakura, and M.Hashida. 1995. The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm. Res. 12 : 825-830.
5. Houk, B.E., R. Martin, G. Hochhaus, and J.A. Hughes. 2001. Pharmacokinetics of plasmid DNA in the rat. Pharm. Res. 18 : 67-74.
6. Yoshida, M., R.I. Mahato, K. Kawabata, Y. Takakura, and M. Hashida. 1996. Disposition characteristics of plasmid DNA in the single-pass rat liver perfusion system. Pharm. Res. 13 : 599-603.
7. Liu, Y., L.C. Mounkes, H.D. Liggitt, C.S. Brown, I. Solodin, T.D. Heath, and R.J. Debs. 1997. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat. Biotechnol. 15 : 167-173.
8. Osaka, G., K. Carey, A. Cuthbertson, P. Godowski, T. Patapoff, A. Ryan, T. Gadek, and J. Mordenti. 1996. Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach. J. Pharm. Sci. 85 : 612-618.
9. Lew, D., S.E. Parker, T. Latimer, A.M. Abai, A. Kuwahara-Rundell, S.G. Doh, Z.Y. Yang, D. Laface, S.H. Gromkowski, and G.J. Nabel. 1995. Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice. Hum. Gene Ther. 6 : 553-564.
10. McClarrinon, M., L. Gilkey, V. Watral, B. Fox, C. Bullock, L. Fradkin, D. Liggitt, L. Roche, L.B. Bussey, E. Fox, and C. Gorman. 1999. In vivo studies of gene expression via transient transgenesis using lipid-DNA delivery. DNA Cell Biol. 18 : 533-547.
11. Anderson, W.F. 1998. Human gene therapy. Nature 392 : 25-30.
12. Lechardeur, D., and G.L. Lukacs. 2002. Intracellular barriers to non-viral gene transfer. Curr. Gene Ther. 2 : 183-194.
13. Cherng, J.Y., N.M. Schuurmans-Nieuwenbroek, W. Jiskoot, H. Talsma, N.J. Zuidam, W.E. Hennink, and D.J. Crommelin. 1999. Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes. J. Control. Release 60 : 343-353.
14. Kano, Y., T. Miyashita, H. Nakamura, K. Kuroki, A. Nagata, and F. Imamoto. 1981. In vivo correlation between DNA supercoiling and transcription. Gene 13 : 173-184.
15. Sekiguchi, J.M., R.A. Swank, and E.B. Kmiec. 1989. Changes in DNA topology can modulate in vitro transcription of certain RNA polymerase III genes. Mol. Cell. Biochem. 85 : 123-133.
16. Pina, B., R.J. Hache, J. Arnemann, G. Chalepakis, E.P. Slater, and M. Beato. 1990. Hormonal induction of transfected genes depends on DNA topology. Mol. Cell. Biol. 10 : 625-633.
17. Ohse, M., K. Kawade, and H. Kusaoke. 1997. Effects of DNA topology on transformation efficiency of Bacillus subtilis ISW1214 by electroporation. Biosci. Biotechnol. Biochem. 61: 1019-1021.
18. Tanswell, A.K., O. Staub, R. Iles, R. Belcastro, J. Cabacungan, L. Sedlackova, B. Steer, Y. Wen, J. Hu, and H. O'Brodovich. 1998. Liposome-mediated transfection of fetal lung epithelial cells: DNA degradation and enhanced superoxide toxicity. Am. J. Physiol. 275:L452-460.
19. Xie, T.D., L. Sun, H.G. Zhao, J.A. Fuchs, and T.Y. Tsong. 1992. Study of mechanisms of electric field-induced DNA transfection. IV. Effects of DNA topology on cell uptake and transfection efficiency. Biophys. J. 63 : 1026-1031.
20. Bergan, D., T. Galbraith, and D.L. Sloane. 2000. Gene transfer in vitro and in vivo by cationic lipids is not significantly affected by levels of supercoiling of a reporter plasmid. Pharm. Res. 17 : 967-973.
21. Herweijer, H., G. Zhang, V.M. Subbotin, V. Budker, P. Williams, and J.A. Wolff. 2001. Time course of gene expression after plasmid DNA gene transfer to the liver. J. Gene Med. 3 : 280-291.
22. Xu, L., T. Daly, C. Gao, T.R. Flotte, S. Song, B.J. Byrne, M.S. Sands, and K. Parker Ponder. 2001. CMV-beta-actin promoter directs higher expression from an adenoassociated viral vector in the liver than the cytomegalovirus or elongation factor 1 α promoter and results in therapeutic levels of human factor X in mice. Hum. Gene Ther. 12 : 563-573.
23. Boussif, O., F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, and J.P. Behr. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92 : 7297-7301.
24. Koltover, I., K. Wagner, and C.R. Safinya. 2000. DNA condensation in two dimensions. Proc. Natl. Acad. Sci. USA 97 : 14046-14051.
25. Takakura, Y., M. Nishikawa, F. Yamashita, and M. Hashida. 2002. Influence of physicochemical properties on pharmacokinetics of non-viral vectors for gene delivery. J. Drug Target. 10 : 99-104.
26. Henner, W.D., I. Kleber, and R. Benzinger. 1973. Transfection of Escherichia coli spheroplasts. 3. Facilitation of transfection and stabilization of spheroplasts by different basic polymers. J. Virol. 12 : 741-747.
27. Boussif, O., F. Lezoualc'h, M.A. Zanta, M.D. Mergny, D. Scherman, B. Demeneix, and J.P. Behr. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA 92(16):7297-7301.
28. Boeckle, S., K. von Gersdorff, S. van der Piepen, C. Culmsee, E. Wagner, and M. Ogris. 2004. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer. J. Gene Med. 6 : 1102-1111.
29. Plank, C., K. Mechtler, F.C. Szoka, Jr., and E. Wagner. 1996. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. 7 : 1437-1446.
30. Ogris, M., S. Brunner, S. Schuller, R. Kircheis, and E. Wagner. 1999. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6 : 595-605.
31. Kircheis, R., L. Wightman, A. Schreiber, B. Robitza, V. Rossler, M. Kursa, and E. Wagner. 2001. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther. 8 : 28-40.
32. Petersen, H., K. Kunath, A.L. Martin, S. Stolnik, C.J. Roberts, M.C. Davies, and T. Kissel. 2002. Star-shaped poly(ethylene glycol)-block-polyethylenimine copolymers enhance DNA condensation of low molecular weight polyethylenimines. Biomacromolecules 3 : 926-936.
33. Ogris, M., P. Steinlein, M. Kursa, K. Mechtler, R. Kircheis, and E. Wagner. 1998. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther. 5 : 1425-1433.
34. Goula, D., C. Benoist, S. Mantero, G. Merlo, G. Levi, and B.A. Demeneix. 1998. Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther. 5 : 1291-1295.
35. Kircheis, R., S. Schuller, S. Brunner, M. Ogris, K.H. Heider, W. Zauner, and E. Wagner. 1999. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J. Gene Med. 1: 111-120.
36. O'Neill, M.M., C.A. Kennedy, R.W. Barton, and R.J. Tatake. 2001. Receptor-mediated gene delivery to human peripheral blood mononuclear cells using anti-CD3 antibody coupled to polyethylenimine. Gene Ther. 8 : 362-368.
37. Suh, W., J.K. Chung, S.H. Park, and S.W. Kim. 2001. Anti-JL1 antibody-conjugated poly (L-lysine) for targeted gene delivery to leukemia Tcells. J. Control. Release 72 : 171-178.
38. Li, S., Y. Tan, E. Viroonchatapan, B.R. Pitt, and L. Huang. 2000. Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am. J. Physiol. Lung Cell. Mol. Physiol. 278:L504-L511.
39. Wu, G.Y., and C.H. Wu. 1987. Receptormediated in vitro gene transformation by a soluble DNA carrier system. J. Biol. Chem. 262 : 4429-4432.
40. Blessing, T., M. Kursa, R. Holzhauser, R. Kircheis, and E. Wagner. 2001. Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug. Chem. 12 : 529-537.
41. Diebold, S.S., M. Kursa, E. Wagner, M. Cotten, and M. Zenke. 1999. Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J. Biol. Chem. 274 : 19087-19094.
42. Erbacher, P., J.S. Remy, and J.P. Behr. 1999. Gene transfer with synthetic viruslike particles via the integrin-mediated endocytosis pathway. Gene Ther. 6 : 138-145.
43. Kircheis, R., A. Kichler, G. Wallner, M. Kursa, M. Ogris, T. Felzmann, M. Buchberger, and E. Wagner. 1997. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4 : 409-418.
44. Nah, J.W., L. Yu, S.O. Han, C.H. Ahn, and S.W. Kim. 2002. Artery wall binding peptide-poly(ethylene glycol)-grafted-poly-(L-lysine)-based gene delivery to artery wall cells. J. Control. Release 78 : 273-284.
45. Lee, H., T.H. Kim, and T.G. Park. 2002. A receptor-mediated gene delivery system using streptavidin and biotin-derivatized, pegylated epidermal growth factor. J. Control. Release 83 : 109-119.
46. Benns, J.M., R.I. Mahato, and S.W. Kim. 2002. Optimization of factors influencing the transfection efficiency of folate-PEGfolate-graft-polyethylenimine. J. Control. Release 79 : 255-269.
47. Erbacher, P., T. Bettinger, P. Belguise-Valladier, S. Zou, J.L. Coll, J.P. Behr, and J.S. Remy. 1999. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J. Gene Med. 1: 210-222.
48. Faraasen, S., J. Voros, G. Csucs, M. Textor, H.P. Merkle, and E. Walter. 2003. Ligandspecific targeting of microspheres to phagocytes by surface modification with poly(L-lysine)-grafted poly(ethylene glycol) conjugate. Pharm. Res. 20 : 237-246.
49. Kursa, M., G.F. Walker, V. Roessler, M. Ogris, W. Roedl, R. Kircheis, and E. Wagner. 2003. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumortargeted gene transfer. Bioconjug. Chem. 14 : 222-231.
50. Boletta, A., A. Benigni, J. Lutz, G. Remuzzi, M.R. Soria, and L. Monaco. 1997. Nonviral gene delivery to the rat kidney with polyethylenimine. Hum. Gene Ther. 8 : 1243-1251.
51. Maheshwari, A., S. Han, R.I. Mahato, and S.W. Kim. 2002. Biodegradable polymerbased interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity. Gene Ther. 9 : 1075-1084.
52. Cohen, H., R.J. Levy, J. Gao, I. Fishbein, V. Kousaev, S. Sosnowski, S. Slomkowski, and G. Golomb. 2000. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 7 : 1896-1905.
53. Lim, Y.B., S.O. Han, H.U. Kong, Y. Lee, J.S. Park, B. Jeong, and S.W. Kim. 2000. Biodegradable polyester, poly[α-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier. Pharm. Res. 17 : 811-816.
54. Luo, D., K. Woodrow-Mumford, N. Belcheva, and W.M. Saltzman. 1999. Controlled DNA delivery systems. Pharm. Res. 16 : 1300-1308.
55. Prabha, S., and Labhasetwar. 2004. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Molecular Pharmaceutics 1: 211-219.
56. Felgner, P.L., T.R. Gadek, M. Holm, R. Roman, H.W. Chan, M. Wenz, J.P. Northrop, G.M. Ringold, and M. Danielsen. 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84 : 7413-7417.
57. Hirko, A., F. Tang, and J.A. Hughes. 2003. Cationic lipid vectors for plasmid DNA delivery. Curr. Med. Chem. 10 : 1185-1193.
58. Hui, S.W., M. Langner, Y.L. Zhao, P. Ross, E. Hurley, and K. Chan. 1996. The role of helper lipids in cationic liposomemediated gene transfer. Biophys. J. 71: 590-599.
59. Sternberg, B., F.L. Sorgi, and L. Huang. 1994. New structures in complex formation between DNA and cationic liposomes visualized by freeze-fracture electron microscopy. FEBS Lett. 356 : 361-366.
60. Stegmann, T., and J.Y. Legendre. 1997. Gene transfer mediated by cationic lipids: lack of a correlation between lipid mixing and transfection. Biochim. Biophys. Acta 1325 : 71-79.
61. Wrobel, I., and D. Collins. 1995. Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim. Biophys. Acta 1235 : 296-304.
62. Wattiaux, R., M. Jadot, M.T. Warnier-Pirotte, and S. Wattiaux-De Coninck. 1997. Cationic lipids destabilize lysosomal membrane in vitro. FEBS Lett. 417 : 199-202.
63. Stamatatos, L., R. Leventis, M.J. Zuckermann, and J.R. Silvius. 1988. Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes. Biochemistry 27 : 3917-3925.
64. Smisterova, J., A. Wagenaar, M.C. Stuart, E. Polushkin, G. ten Brinke, R. Hulst, J.B. Engberts, and D. Hoekstra. 2001. Molecular shape of the cationic lipid controls the structure of cationic lipid/dioleylphosphatidylethanolamine-DNA complexes and the efficiency of gene delivery. J. Biol. Chem. 276 :47615-47622.
65. Nicolazzi, C., N. Mignet, N. de la Figuera, M. Cadet, R.T. Ibad, J. Seguin, D. Scherman, and M. Bessodes. 2003. Anionic polyethyleneglycol lipids added to cationic lipoplexes increase their plasmatic circulation time. J. Control. Release 88 : 429-443.
66. Meyer, O., D. Kirpotin, K. Hong, B. Sternberg, J.W. Park, M.C. Woodle, and D. Papahadjopoulos. 1998. Cationic liposomes coated with polyethylene glycol as carriers for oligonucleotides. J. Biol. Chem. 273 : 15621-15627.
67. Pires, P., S. Simoes, S. Nir, R. Gaspar, N. Duzgunes, and M.C. Pedroso de Lima. 1999. Interaction of cationic liposomes and their DNA complexes with monocytic leukemia cells. Biochim. Biophys. Acta 1418 : 71-84.
68. Mahato, R.I. 2005. Water insoluble and soluble lipids for gene delivery. Adv. Drug Deliv. Rev. 57 : 699-712.
69. Mahato, R.I., K. Anwer, F. Tagliaferri, C. Meaney, P. Leonard, M.S. Wadhwa, M. Logan, M. French, and A. Rolland. 1998. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum. Gene Ther. 9: 2083-2099.
70. Hofland, H.E., D. Nagy, J.J. Liu, K. Spratt, Y.L. Lee, O. Danos, and S.M. Sullivan. 1997. In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex. Pharm. Res. 14 : 742-749.
71. Zhu, N., D. Liggitt, Y. Liu, and R. Debs. 1993. Systemic gene expression after intravenous DNA delivery into adult mice. Science 261: 209-211.
72. Thierry, A.R., Y. Lunardi-Iskandar, J.L. Bryant, P. Rabinovich, R.C. Gallo, and L.C. Mahan. 1995. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc. Natl. Acad. Sci. USA 92 : 9742-9746.
73. Liu, Y., D. Liggitt, W. Zhong, G. Tu, K. Gaensler, and R. Debs. 1995. Cationic liposome-mediated intravenous gene delivery. J. Biol. Chem. 270 : 24864-24870.
74. Hofland, H.E., D. Nagy, J.J. Liu, K. Spratt, Y.L. Lee, O. Danos, and S.M. Sullivan. 1997. In-vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex. Pharm. Res. 14 : 742-749.
75. Berns, K.I., and C. Giraud. 1996. Biology of adeno-associated virus. Curr. Top. Microbiol. Immunol. 218 : 1-23.
76. McLaughlin, S.K., P. Collis, P.L. Hermonat, and N. Muzyczka. 1988. Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62 : 1963-1973.
77. Leopold, P.L., B. Ferris, I. Grinberg, S. Worgall, N.R. Hackett, and R.G. Crystal. 1998. Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum. Gene Ther. 9 : 367-378.
78. Linden, R.M., P. Ward, C. Giraud, E. Winocour, and K.I. Berns. 1996. Sitespecific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 93 : 11288-11294.
79. Miao, C.H., H. Nakai, A.R. Thompson, T.A. Storm, W. Chiu, R.O. Snyder, and M.A. Kay. 2000. Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction. J. Virol. 74 : 3793-3803.
80. Summerford, C., J.S. Bartlett, and R.J. Samulski. 1999. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5 : 78-82.
81. Gonin, P., and C. Gaillard. 2004. Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development. Gene Ther. 11(Suppl 1): S98-S108.
82. Ponnazhagan, S., M.J. Woody, X.S. Wang, S.Z. Zhou, and A. Srivastava. 1995. Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2. J. Virol. 69 : 8096-8101.
83. Watson, G.L., J.N. Sayles, C. Chen, S.S. Elliger, C.A. Elliger, N.R. Raju, G.J. Kurtzman, and G.M. Podsakoff. 1998. Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus. Gene Ther. 5 : 1642-1649.
84. Nathwani, A.C., A. Davidoff, H. Hanawa, J.F. Zhou, E.F. Vanin, and A.W. Nienhuis. 2001. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Blood 97 : 1258-1265.
85. Lai, L., B.B. Davison, R.S. Veazey, K.J. Fisher, G.B. Baskin. 2000. A preliminary evaluation of recombinant adenoassociated virus biodistribution in rhesus monkeys after intrahepatic inoculation in utero. Hum. Gen. Ther. 13: 2027-2039.
86. Favre, D., N. Provost, V. Blouin, G. Blancho, Y. Cherel, A. Salvetti, and P. Moullier. 2001. Immediate and longterm safety of recombinant adeno-associated virus injection into the nonhuman primate muscle. Mol. Ther. 4 : 559-566.
87. Arruda, V.R., P.A. Fields, R. Milner, L. Wainwright, M.P. De Miguel, P.J. Donovan, R.W. Herzog, T.C. Nichols, J.A. Biegel, M. Razavi, M. Dake, D. Huff, A.W. Flake, L. Couto, M.A. Kay, and K.A. High. 2001. Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males. Mol. Ther. 4: 586-592.
88. Zinn, K.R., J.T. Douglas, C.A. Smyth, H.G. Liu, Q. Wu, V.N. Krasnykh, J.D. Mountz, D.T. Curiel, and J.M. Mountz. 1998. Imaging and tissue biodistribution of 99mTc-labeled adenovirus knob (serotype 5). Gene Ther. 5 : 798-808.
89. Burger, C., O.S. Gorbatyuk, M.J. Velardo, C.S. Peden, P. Williams, S. Zolotukhin, P.J. Reier, R.J. Mandel, and N. Muzyczka. 2004. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 10 : 302-317.
90. De, B., A. Heguy, P.L. Leopold, N. Wasif, R.J. Korst, N.R. Hackett, and R.G. Crystal. 2004. Intrapleural administration of a serotype 5 adeno-associated virus coding for α1-antitrypsin mediates persistent, high lung and serum levels of α1-antitrypsin. Mol. Ther. 10 : 1003-1010.
91. Gao, G.P., M.R. Alvira, L. Wang, R. Calcedo, J. Johnston, and J.M. Wilson. 2002. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99 : 11854-11859.